Information for Authors
The Lancet Rheumatology publishes any original research contribution that illuminates or influences clinical practice, directly informs future clinical trials, or substantively improves our understanding of disease processes. The Lancet Rheumatology also publishes interesting and informative reviews on any topic within the spectrum of rheumatology. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties and countries.
The journal publishes a range of article types that encompass all aspects of rheumatology: Comment, Correspondence, News, Article, Review, Health Policy, and Viewpoint.
All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published within 8 weeks from submission. Most accepted Articles will be published online first before appearing in an issue of the journal. Wherever possible, figures and good quality photographs should be used to supplement and to enhance the text. We also welcome videos. All original research is subjected to the Lancet family of journals’ usual rigorous standards of external clinical and statistical peer review, and edited by experienced technical copy editors to the highest standards.
The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations) and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.
If your question is not addressed on these pages, please email the editorial staff at [email protected]
